FIELD: organic chemistry, biochemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new derivatives of mycanolide of the formula (I): corresponding to the general subformulae (I)1 and (I)2 wherein L, R1 and R2 have values given in the invention description. Also, invention relates to a medicinal agent and pharmaceutical composition based on compounds of the formula (I), and to using compounds of the formula (I) for preparing a medicinal agent designated for inhibition of activity of DNA polymerases and treatment of diseases arising as result of anomalous cellular proliferation. Invention provides preparing new derivatives of mycanolide possessing the valuable pharmaceutical effect.
EFFECT: valuable medicinal and biochemical properties of derivatives.
12 cl, 2 tbl, 52 ex
Title | Year | Author | Number |
---|---|---|---|
GRISEOFULVIN COMPOUND | 2017 |
|
RU2736208C2 |
NEW ALKYLATING AGENTS | 2013 |
|
RU2632206C2 |
14,17-C-BRIDGE STEROIDS AND PHARMACEUTICAL PREPARATION | 1995 |
|
RU2169153C2 |
METHOD OF OBTAINING BENZO[b][1,4]DIAZEPINE-2,4-DIONE DERIVATIVE | 2010 |
|
RU2553676C2 |
DIAZABICYCLOALKENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2126008C1 |
DERIVATIVES OF CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUNDS AND METHOD OF THEIR SYNTHESIS | 1996 |
|
RU2167877C2 |
TRIAROMATIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF AND THEIR USE | 1998 |
|
RU2149863C1 |
LUMINOPHORES BASED ON 2,6-BIS(AMINOVINYL)-4-METHYLENE-1,4-DIHYDROPYRIDINE AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2824353C1 |
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
DERIVATIVE OF TRIAZASPIRO[5,5]UNDECANE AND PHARMACEUTICAL COMPOSITION COMPRISING ITS AS ACTIVE COMPONENT | 2002 |
|
RU2269528C2 |
Authors
Dates
2006-06-20—Published
2002-01-11—Filed